Alzheimer's disease, a form of dementia, has a significant genetic component. While age remains the greatest risk factor, several genes play roles in its development. The APOE gene, particularly the ε4 allele, increases susceptibility, influencing the age of onset and progression. Mutations in genes like APP, PSEN1, and PSEN2 are linked to rare, early-onset familial forms of Alzheimer's. However, genetic factors alone do not determine disease onset; environmental and lifestyle factors also contribute. Research continues to uncover new genetic variants and pathways involved in Alzheimer's, aiding in earlier diagnosis and potential therapeutic targets. Understanding these genetic foundations is crucial for developing personalized treatments and interventions aimed at delaying or preventing the disease.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China